Millendo Therapeutics, Inc. Human Resources Contracts & Agreements
54 Contracts & Agreements
- Bonus & Incentive Agreements (24 contracts)
- Compensation Agreements (5)
- Consulting Agreements (3)
- Employment Agreements (17)
- Separation Agreements (5)
- Separation and Consulting Agreement by and between the Registrant and Tom Dubensky, Ph.D., dated September 15, 2023 (Filed With SEC on November 8, 2023)
- Form of Option Grant Package under the Amended and Restated 2023 Equity Incentive Plan (Filed With SEC on August 10, 2023)
- Tempest Therapeutics, Inc. Amended and Restated 2023 Equity Incentive Plan (Filed With SEC on August 10, 2023)
- Tempest Therapeutics, Inc. Amended and Restated 2019 Equity Incentive Plan (Filed With SEC on June 21, 2022)
- Executive Employment Agreement, dated January 12, 2022, by and between the Company and Nicholas Maestas (Filed With SEC on May 13, 2022)
- Executive Employment Agreement, dated January 12, 2022, by and between the Company and Samuel Whiting, M.D., Ph.D (Filed With SEC on May 13, 2022)
- Executive Employment Agreement, dated January 12, 2022, by and between the Company and Thomas Dubensky (Filed With SEC on May 13, 2022)
- Executive Employment Agreement, dated January 12, 2022, by and between the Company and Stephen Brady (Filed With SEC on May 13, 2022)
- Form of Stock Option Agreement under the 2017 Equity Incentive Plan (Filed With SEC on March 29, 2022)
- Employment Agreement, dated July 7, 2021, by and between the Company and Samuel Whiting, M.D., Ph.D (Filed With SEC on July 7, 2021)
- Employment Agreement, dated July 7, 2021, by and between the Company and Thomas Dubensky, Ph.D (Filed With SEC on July 7, 2021)
- Employment Agreement, dated July 7, 2021, by and between the Company and Stephen Brady (Filed With SEC on July 7, 2021)
- Amended and Restated Employment Agreement between Jennifer Minai-Azary and Millendo Therapeutics US, Inc., dated of January 27, 2021 (Filed With SEC on March 29, 2021)
- Amended and Restated Employment Agreement between Louis Arcudi III and Millendo Therapeutics US, Inc., dated as of January 27, 2021 (Filed With SEC on March 29, 2021)
- Separation from Employment, by and between Millendo Therapeutics US, Inc. and Julia C. Owens, Ph.D., dated January 27, 2021 (Filed With SEC on March 29, 2021)
- Separation Agreement, by and among Millendo Therapeutics, Inc. and Ryan K. Zeidan, dated January 25, 2021 (Filed With SEC on January 28, 2021)
- Amendment to the Millendo Therapeutics, Inc. 2019 Equity Incentive Plan (Filed With SEC on June 23, 2020)
- Amendment to the Millendo Therapeutics, Inc. (formerly OvaScience, Inc.) 2012 Stock Incentive Plan (Filed With SEC on June 23, 2020)
- Employment Agreement between Christophe Arbet-Engels and Millendo Therapeutics US, Inc., dated as of February 5, 2020 (Filed With SEC on March 11, 2020)
- Form of Inducement Nonqualified Stock Option Agreement subject to the terms of the 2019 Equity Incentive Plan (Filed With SEC on March 11, 2020)
- Form of Stock Option Agreement under the Sub Plan for French Residents under 2019 Equity Incentive Plan (Filed With SEC on March 11, 2020)
- Form of Inducement Nonqualified Stock Option Agreement subject to the terms of the OvaScience 2012 Stock Incentive Plan (Filed With SEC on March 11, 2020)
- Consulting Agreement, by and between the Registrant and Jeffery Brinza, dated August 23, 2019 (Filed With SEC on November 13, 2019)
- Employment Agreement, by and between Millendo Therapeutics US, Inc. and Tamara Joseph, dated July 11, 2019 (Filed With SEC on November 13, 2019)
- Amended and Restated Employment Agreement, by and between Millendo Therapeutics US, Inc. and Ryan Zeidan, dated August 16, 2019 (Filed With SEC on November 13, 2019)
- Form of RSU Grant Package under 2019 Equity Incentive Plan (Filed With SEC on August 12, 2019)
- Form of Option Grant Package under 2019 Equity Incentive Plan (Filed With SEC on August 12, 2019)
- Amended and Restated Employment Agreement, by and between Millendo Therapeutics US, Inc. and Jeffery M. Brinza, dated May 23, 2019 (Filed With SEC on August 12, 2019)
- Amended and Restated Employment Agreement, by and between Millendo Therapeutics US, Inc. and Louis Arcudi III, dated June 19, 2019 (Filed With SEC on August 12, 2019)
- Amended and Restated Employment Agreement, by and between Millendo Therapeutics US, Inc. and Julia C. Owens, Ph.D., dated June 19, 2019 (Filed With SEC on August 12, 2019)
- 2019 Equity Incentive Plan (Filed With SEC on June 13, 2019)
- Form of Stock Option Agreement under the Millendo Therapeutics, Inc. 2012 Stock Incentive Plan (Filed With SEC on April 1, 2019)
- Millendo Therapeutics, Inc. 2012 Stock Incentive Plan, as amended (Filed With SEC on April 1, 2019)
- Separation Agreement by and between OvaScience, Inc. and James Lillie, Ph.D., dated as of December 5, 2018 (Filed With SEC on December 6, 2018)
- Separation Agreement by and between OvaScience, Inc. and Jonathan Gillis, C.P.A., dated as of December 5, 2018 (Filed With SEC on December 6, 2018)
- Separation Agreement by and between OvaScience, Inc. and Christopher A. Kroeger, M.D., M.B.A., dated as of December 5, 2018 (Filed With SEC on December 6, 2018)
- Employment Terms between Louis Arcudi III and Millendo Therapeutics, Inc., dated as of November 1, 2018 (Filed With SEC on November 26, 2018)
- INDEPENDENT CONSULTING AGREEMENT (Filed With SEC on May 5, 2016)
- OVASCIENCE, INC. Restricted Stock Unit Award Grant Notice Restricted Stock Unit Award Grant under the Companys 2012 Stock Incentive Plan (Filed With SEC on May 5, 2016)
- OVASCIENCE, INC. Nonstatutory Stock Option Agreement Granted Under 2012 Stock Incentive Plan (Filed With SEC on May 5, 2016)
